GENEVA, July 1 -- ADCYTHERIX SAS (17 Boulevard Augustin Cieussa13007 Marseille) filed a patent application (PCT/EP2024/087579) for "NOVEL ANTIBODY-DRUG CONJUGATES COMPRISING AN ANTI-(TCR)-CD3-COMPLEX BINDING ANTIBODY" on Dec 19, 2024. With publication no. WO/2025/132907, the details related to the patent application was published on Jun 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PREVILLE, Xavier (502 Chemin de Peire Luche06330 Roquefort les Pins), ELANDS, Jack (Avenue Clementine 31190 Forest)
Abstract:
The present invention relates to novel antibody-drug conjugates comprising a m...